Nuocheng Bio has released a performance forecast, which is expected to achieve a net income attributable to the owner of the parent company of 180 million yuan to 250 million yuan in the first half of 2024, a year-on-year increase of 330.08% to 497.34%.
诺泰生物：2024年半年度净利润同比增加330.08%到497.34%
In the first half of 2024, the net income is expected to increase by 330.08% to 497.34% year-on-year for Nuocheng Bio.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.